Dose–response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys
Background and purpose: The non‐selective β‐adrenoceptor antagonist, D,L‐sotalol (sotalol) is commonly employed as a positive control during preclinical cardiovascular safety pharmacology testing, mainly because of its ability to prolong QT interval duration. However, no information appears in the l...
Saved in:
Published in | British journal of pharmacology Vol. 154; no. 7; pp. 1439 - 1445 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2008
Nature Publishing Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!